Hagar Khalid

Dr. Hagar Khalid


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Ophthalmology
Verified
Journal Article
Open access
GMGabriella Moraes
Gabriella Moraes
DFDun Jack Fu
Dun Jack Fu
MWMarc Wilson
Marc Wilson
HKHagar Khalid
Hagar Khalid
SWSiegfried K. Wagner
Siegfried K. Wagner
RCReena Chopra
Reena Chopra
To apply a deep learning algorithm for automated, objective, and comprehensive quantification of OCT scans to a large real-world dataset of eyes with neovascular age-related macular degeneration (AMD) and make the raw segmentation output data openly available for further research. Retrospective analysis of OCT images from the Moorfields Eye Hospital AMD Database. A total of 2473 first-treated eyes and 493 second-treated eyes that commenced therapy for neovascular AMD between June 2012 and June 2017. A deep learning algorithm was used to segment all baseline OCT scans. Volumes were calculated for segmented features such as neurosensory retina (NSR), drusen, intraretinal fluid (IRF), subretinal fluid (SRF), subretinal hyperreflective material (SHRM), retinal pigment epithelium (RPE), hyperreflective foci (HRF), fibrovascular pigment epithelium detachment (fvPED), and serous PED (sPED). Analyses included comparisons between first- and second-treated eyes by visual acuity (VA) and race/ethnicity and correlations between volumes. Volumes of segmented features (mm3) and central subfield thickness (CST) (μm). In first-treated eyes, the majority had both IRF and SRF (54.7%). First-treated eyes had greater volumes for all segmented tissues, with the exception of drusen, which was greater in second-treated eyes. In first-treated eyes, older age was associated with lower volumes for RPE, SRF, NSR, and sPED; in second-treated eyes, older age was associated with lower volumes of NSR, RPE, sPED, fvPED, and SRF. Eyes from Black individuals had higher SRF, RPE, and serous PED volumes compared with other ethnic groups. Greater volumes of the majority of features were associated with worse VA. We report the results of large-scale automated quantification of a novel range of baseline features in neovascular AMD. Major differences between first- and second-treated eyes, with increasing age, and between ethnicities are highlighted. In the coming years, enhanced, automated OCT segmentation may assist personalization of real-world care and the detection of novel structure–function correlations. These data will be made publicly available for replication and future investigation by the AMD research community.

24 January 2020 in Eye
Verified
Journal Article
Closed access
PDF file
SCShruti Chandra
Shruti Chandra
CACristina Arpa
Cristina Arpa
DMDeepthy Menon
Deepthy Menon
HKHagar Khalid
Hagar Khalid
RHRobin Hamilton
Robin Hamilton
SSSobha Sivaprasad
Sobha Sivaprasad

19 March 2020 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
HKHagar Khalid
Hagar Khalid
RSRoy Schwartz
Roy Schwartz
LNLuke Nicholson
Luke Nicholson
JHJosef Huemer
Josef Huemer
MEMohamed Hosny El-Bradey
Mohamed Hosny El-Bradey
RRRanjan Rajendram
Ranjan Rajendram
Purpose To evaluate the utility of widefield optical coherence tomography angiography (WF-OCTA) compared with clinical examination in grading diabetic retinopathy in patients diagnosed clinically with proliferative diabetic retinopathy (PDR) or severe non-proliferative diabetic retinopathy (NPDR). Design This retrospective observational case series included patients diagnosed clinically with PDR or severe NPDR. Patients underwent standard clinical examination and WF-OCTA imaging (PLEX Elite 9000, Carl Zeiss Meditec AG) using 12×12 montage scans between August 2018 and January 2019. Two trained graders identified neovascularisation at the disc (NVD) and neovascularisation elsewhere (NVE) on WF-OCTA which were compared with the clinical examination, and to ultra-widefield fluorescein angiography (UWFA) when available. Results Seventy-nine eyes of 46 patients were evaluated. Of those, 57 eyes were diagnosed clinically with PDR, and 22 with severe NPDR. NVD was detected on OCTA-B scan as preretinal hyperreflective material (PRHM) in 39 eyes (100%) with evident flow signals in 79.5% compared with 51.3% detected clinically. We further classified NVD on OCTA into four subtypes and found that subtypes 1 and 2 could not be seen on clinical examination alone. WF-OCTA detected NVE in 81% of the cases compared with 55.7% detected clinically. Using WF-OCTA resulted in a higher percentage of PDR grading (88.6%) than on clinical examination (72.2%). When available, UWFA confirmed the WF-OCTA diagnosis in the majority of cases. Conclusion This study demonstrates that WF-OCTA has a higher detection rate of PDR than clinical examination. This suggests that this modality could be used non-invasively for the purpose of early detection and characterisation of neovascularisation.

1 February 2020 in Ophthalmology Retina
Verified
Journal Article
Closed access
RSRoy Schwartz
Roy Schwartz
HKHagar Khalid
Hagar Khalid
SSSobha Sivaprasad
Sobha Sivaprasad
LNLuke Nicholson
Luke Nicholson
EAEvgenia Anikina
Evgenia Anikina
PKPearse Keane
Pearse Keane

30 November 2020 in Eye
Verified
Journal Article
Closed access
PDF file
JHJosef Huemer
Josef Huemer
HKHagar Khalid
Hagar Khalid
SWSiegfried K. Wagner
Siegfried K. Wagner
LNLuke Nicholson
Luke Nicholson
DFDun Jack Fu
Dun Jack Fu
PKPearse Keane
Pearse Keane

Verified
Journal Article
Open access
PDF file
AHAhmed Hagag
Ahmed Hagag
SCShruti Chandra
Shruti Chandra
HKHagar Khalid
Hagar Khalid
ALAli Lamin
Ali Lamin
PKPearse Keane
Pearse Keane
SSSobha Sivaprasad
Sobha Sivaprasad
The diagnosis and treatment of choroidal neovascularization (CNV) in eyes with chronic central serous chorioretinopathy (CSCR) can be challenging. The purpose of this study was to classify eyes with suspected CNV using multimodal imaging. The effect of intravitreal anti-vascular endothelial growth factor (VEGF) was assessed and compared to controls. This retrospective study included chronic CSCR patients with suspected secondary CNV who received intravitreal bevacizumab. Eyes were divided into “definite CNV” and “no CNV” based on optical coherence tomography angiography (OCTA). Eyes that did not undergo OCTA imaging were considered as “presumed CNV”. One-year outcome in visual acuity (VA) and central foveal thickness (CFT) were investigated and compared to non-treated control patients to assess the response to anti-VEGF. Logistic regression analysis was used to explore predictive biomarkers of CNV detection and improvement after anti-VEGF. Ninety-two eyes with chronic CSCR from 88 participants were included in this study. Sixty-one eyes received bevacizumab and 31 eyes were non-treated control subjects. The presence of subretinal hyperreflective material (SHRM) and shallow irregular retinal pigment epithelium (RPE) elevation (SIRE) with sub-RPE hyperreflectivity on OCT was associated with a significantly increased risk of detecting CNV on OCTA. Intravitreal anti-VEGF caused significant functional and anatomical improvement in patients with neovascular CSCR as compared to non-treated eyes. In contrast, VA and CFT changes were not significantly different between treated and non-treated CSCR with no evidence of CNV on OCTA. No clinical or anatomical biomarkers were found to be associated with response to treatment. In conclusion, OCTA should be used to confirm the presence CNV in suspected chronic CSCR patients. Intravitreal anti-VEGF treatment resulted in a significantly better one-year outcome in patients with definitive OCTA evidence of CNV.